Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of H5N1 Vaccine in Adults
NCT00545701Phase 2Completed
- Sponsor
- Sanofi
- Start
- Oct 2007
- Primary completion
- Jun 2008
- Modality
- Split/Subunit Vaccines, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of Influenza A (H5N1) vaccine in Influenza A H5N1 infection (H5N1), sponsored by Sanofi. Started Oct 2007; status: completed.
02
Drugs
Influenza A (H5N1) vaccine
03
Conditions
Influenza A H5N1 infection (H5N1)
Beyond the preview
Go deeper on NCT00545701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545701.